Diabetes Research and Clinical Practice
Volume 72, Issue 3 , Pages 244-250 , June 2006

Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity

  • Guoyue Yuan

      Affiliations

    • Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai, 197, Ruijin Road II, Shanghai 200025, China
    • These authors contributed equally to this work.
    • ,
  • Libin Zhou

      Affiliations

    • Shanghai Institute of Endocrine and Metabolic Diseases, 197, Ruijin Road II, Shanghai 200025, China
    • These authors contributed equally to this work.
    • ,
  • Jinfeng Tang

      Affiliations

    • Shanghai Institute of Endocrine and Metabolic Diseases, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Ying Yang

      Affiliations

    • Shanghai Institute of Endocrine and Metabolic Diseases, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Weiqiong Gu

      Affiliations

    • Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Fengying Li

      Affiliations

    • Shanghai Institute of Endocrine and Metabolic Diseases, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Jie Hong

      Affiliations

    • Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Yanyun Gu

      Affiliations

    • Shanghai Institute of Endocrine and Metabolic Diseases, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Xiaoying Li

      Affiliations

    • Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Guang Ning

      Affiliations

    • Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai, 197, Ruijin Road II, Shanghai 200025, China
    • ,
  • Mingdao Chen

      Affiliations

    • Ruijin Hospital Affiliated to Shanghai Second Medical University, Shanghai, 197, Ruijin Road II, Shanghai 200025, China
    • Shanghai Institute of Endocrine and Metabolic Diseases, 197, Ruijin Road II, Shanghai 200025, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 21 64315587; fax: +86 21 64673639.

Received 29 June 2005 ,Revised 12 September 2005 ,Accepted 26 October 2005.

References 

  1. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koeig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1386–1392
  2. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237–242
  3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  4. Ridker PM. High-sensitivity C-reactive protein Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  5. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
  6. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc. 2001;286:327–334
  7. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001;50:2384–2389
  8. Freeman DJ, Nome J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51:1596–1600
  9. Festa A, D’Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes. 2002;51:1131–1137
  10. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study. Arch Intern Med. 2003;163:93–99
  11. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23:1835–1839
  12. Lemieux I, Pascot A, Prud’homme D, Almeras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21:961–967
  13. Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabetic Med. 2003;21:39–44
  14. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al. Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract. 2004;64:99–106
  15. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32:47–50
  16. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473–2476
  17. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96:1723–1732
  18. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103:1057–1063
  19. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–946
  20. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–1935
  21. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  22. Tang J, Yang Y, Wang Q, Li J, Gu W, Hong J, et al. Relationship between serum adiponectin concentration and adiposity. Chin J Endocrinol Metab. 2003;19:166–168
  23. Gu W, Hong J, Zhang Y, Chen Y, Zhao H, Tang J, et al. Relationship among serum leptin, free fatty acid and adiponectin levels in obesity. Chin J Endocrinol Metab. 2003;19:169–172
  24. Hong J, Gu W, Zhang Y, Tang J, Yang Y, Chen Y, et al. Study of correlation between serum adiponectin level and insulin sensitivity in patients with insulin resistance syndrome. Chin J Endocrinol Metab. 2003;19:173–176
  25. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin protects against development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–58
  26. Festa A, Hanley AJG, Tracy RP, D’Agostino R, Haffher SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation. 2003;108:1822–1830
  27. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol. 2003;148:657–662
  28. Shand BI, Scott RS, Elder PA, George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab. 2003;5:349–353
  29. Schulze MB, Rimm EB, Shai I, Rifai N, Hu FB. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004;27:1680–1687
  30. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: Department of Noncommunicable Disease Surveillance, 1999. WHO/NCD/NCS/99.2.
  31. Steil GM, Volund A, Kahn SE, et al. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: suitability for use in population studies. Diabetes. 1993;42:250–256
  32. O’Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ, et al. Insulin and counterregulatory honnones influence acute-phase protein production in human hepatocytes. Am J Physiol. 1995;269:E323–E330
  33. Temelkova-Kurktschiev T, Henkel E, Koehler C, Karrei K, Hanefeld M. Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance (Letter). Diabetologia. 2002;45:151
  34. Hotta K, Funahushi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentration of a novel adipose-specific protein, adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–1599
  35. Wu T, Dorn JP, Donahue RP, Sempos CT, Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Surveydkjdot. Am J Epidemiol. 2002;155:65–71
  36. Li G, Wang J, Chen C. Model of development of diabetes mellitus in adult Chinese. Natl Med J China. 2001;81:914–917
  37. Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system?. Diabetologia. 1998;41:1241–1248
  38. Campos SP, Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Moll Cell Biol. 1992;12:1789–1797
  39. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000;148:209–214
  40. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin /ACRP30. Nat Med. 2002;8:731–737
  41. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis-the missing link of adipo-vascular axis. J Biol Chem. 2002;277:37487–37491
  42. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671

PII: S0168-8227(05)00430-4

doi: 10.1016/j.diabres.2005.10.025

Diabetes Research and Clinical Practice
Volume 72, Issue 3 , Pages 244-250 , June 2006

Article Tools

* Image Usage & Resolution